165 related articles for article (PubMed ID: 32563206)
1. Clinical significance of Candida isolation from dystrophic fingernails.
Shemer A; Daniel R; Lyakhovitsky A; Aghion-Svirsky V; Kassem R; Rigopoulos D; Farhi R; Galili E
Mycoses; 2020 Sep; 63(9):964-969. PubMed ID: 32563206
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors influencing the treatment outcome of onychomycosis Candida.
Widaty S; Miranda E; Bramono K; Menaldi SL; Marissa M; Oktarina C; Surya D; Kusumawardhani HT
Mycoses; 2020 Jan; 63(1):71-77. PubMed ID: 31603597
[TBL] [Abstract][Full Text] [Related]
3. Onychomycosis secondary to onychomadesis: an underdiagnosed manifestation.
Li M; Chen Z; Yin S; Xue R; Chen Z; Huang H; Wei L; Lu C; De Hoog GS; Lai W; Feng P
Mycoses; 2017 Mar; 60(3):161-165. PubMed ID: 27618806
[TBL] [Abstract][Full Text] [Related]
4. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D
Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481
[TBL] [Abstract][Full Text] [Related]
5. Onchomycosis: an overview.
Elewski BE; Rich P; Tosti A; Pariser DM; Scher R; Daniel RC; Gupta AK
J Drugs Dermatol; 2013 Jul; 12(7):s96-103. PubMed ID: 23884508
[TBL] [Abstract][Full Text] [Related]
6. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Ranawaka RR; Nagahawatte A; Gunasekara TA
Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
[TBL] [Abstract][Full Text] [Related]
7. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
Khosravi AR; Mansouri P
Mycopathologia; 2001; 150(1):9-13. PubMed ID: 11392568
[TBL] [Abstract][Full Text] [Related]
8. Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement.
Chularojanamontri L; Pattanaprichakul P; Leeyaphan C; Suphatsathienkul P; Wongdama S; Bunyaratavej S
Biomed Res Int; 2021; 2021():9113418. PubMed ID: 34938812
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.
Savin RC; Drake L; Babel D; Stewart DM; Rich P; Ling MR; Breneman D; Scher RK; Martin AG; Pariser DM; Pariser RJ; Ellis CN; Kang S; Friedman D; Katz HI; McDonald CJ; Muglia J; Webster G; Elewski BE; Leyden JJ; Bucko AD; Tschen EH; Hanifin JM; Morman MR; Hilbert J
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S110-6. PubMed ID: 9631993
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.
Ranawaka RR; de Silva SH
Int J Dermatol; 2017 Feb; 56(2):202-208. PubMed ID: 27813064
[TBL] [Abstract][Full Text] [Related]
11. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.
Drake L; Babel D; Stewart DM; Rich P; Ling MR; Breneman D; Scher RK; Martin AG; Pariser DM; Pariser RJ; Ellis CN; Kang S; Katz HI; McDonald CJ; Muglia J; Savin RC; Webster G; Elewski BE; Leyden JJ; Bucko AD; Tschen EH; Hanifin JM; Morman MR; Shupack JL; Greer DL
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S87-94. PubMed ID: 9631990
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
[TBL] [Abstract][Full Text] [Related]
13. Study of onychomycosis in Córdoba, Spain: prevailing fungi and pattern of infection.
Vélez A; Linares MJ; Fenández-Roldán JC; Casal M
Mycopathologia; 1997; 137(1):1-8. PubMed ID: 9299751
[TBL] [Abstract][Full Text] [Related]
14. Distal and lateral subungual onychomycosis of the finger nail in a neonate: a rare case.
Subramanya SH; Subedi S; Metok Y; Kumar A; Prakash PY; Nayak N
BMC Pediatr; 2019 May; 19(1):168. PubMed ID: 31133007
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibility of non-albicans Candida species causing fingernail onychomycosis.
Upton A; Rogers K; Wood N; Morris AJ
N Z Med J; 2004 Sep; 117(1201):U1060. PubMed ID: 15476017
[No Abstract] [Full Text] [Related]
16. Onychomycosis: Diagnosis and management.
Singal A; Khanna D
Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
[TBL] [Abstract][Full Text] [Related]
17. Candida onychomycosis--an evaluation of the role of Candida species in nail disease.
Hay RJ; Baran R; Moore MK; Wilkinson JD
Br J Dermatol; 1988 Jan; 118(1):47-58. PubMed ID: 3342176
[TBL] [Abstract][Full Text] [Related]
18. [Antimycotic therapy of Tinea unguium and other onychomycoses].
Stock I
Med Monatsschr Pharm; 2009 Aug; 32(8):289-98; quiz 299-300. PubMed ID: 19777736
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment.
Grynszpan R; Barreiros G; do Nascimento Paixão M; Frasnelli Fernandes M; Aguinaga F; Camargo C; Ramos-E-Silva M; Carneiro S
Mycoses; 2021 Sep; 64(9):1092-1097. PubMed ID: 34061419
[TBL] [Abstract][Full Text] [Related]
20. Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial.
Grover C; Bansal S; Nanda S; Reddy BS; Kumar V
Br J Dermatol; 2007 Aug; 157(2):364-8. PubMed ID: 17573877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
